Rchr
J-GLOBAL ID：201901000004985406   Update date: Jan. 30, 2024

Mutoh Tomoyuki

ムトウ トモユキ | Mutoh Tomoyuki
Affiliation and department：
Tohoku University

About Tohoku University


Research field  (1)： Allergies and connective tissue disease
Research keywords  (5)： 関節リウマチ ,  抗血管内皮細胞抗体 ,  血管炎 ,  自己抗体 ,  高安動脈炎
Research theme for competitive and other funds  (1)：
  • 2020 - 2024 高安動脈炎における新規自己抗体の病原性の解明
Papers (14)：
  • Tomoyuki Mutoh, Mamoru Narita, Taichi Nagai, Sadanori Furudate, Shinji Taniuchi, Masataka Kudo, Hiroshi Fujii. Clinical Images: Multiple punched-out ulcerations on the abdomen in anti-melanoma differentiation-associated gene 5 dermatomyositis. Arthritis & rheumatology (Hoboken, N.J.). 2023
  • Tomoyuki Mutoh, Keiichi Ohashi, Taichi Nagai, Akira Sugiura, Masataka Kudo, Hiroshi Fujii. Upfront rituximab therapy for thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case-based review. Rheumatology international. 2023. 43. 2. 373-381
  • Tomoyuki Mutoh, Tsuyoshi Shrai, Hiroshi Fujii. Comment on: Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis. Rheumatology (Oxford, England). 2022
  • Tomoyuki Mutoh, Taichi Nagai, Tsuyoshi Shirai, Soshi Okazaki, Hiroko Sato, Hiroshi Fujii. Predictive factors for retention of golimumab over a median 4-year duration in Japanese patients with rheumatoid arthritis in a real-world setting: A retrospective study and literature review. International journal of rheumatic diseases. 2022. 25. 3. 335-343
  • Tomoyuki Mutoh, Tsuyoshi Shirai, Hiroko Sato, Hiroshi Fujii, Tomonori Ishii, Hideo Harigae. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review. Rheumatology international. 2021. 42. 11. 2069-2076
ｍore...
MISC (5)：
Lectures and oral presentations  (10)：
  • Endothelial Protein C Receptor and Scavenger Receptor Class B Type 1 Negatively Regulate Vascular Inflammation and Are Major Autoantigens in Takayasu Arteritis
    (American College of Rheumatology Annual Meeting 2019 2019)
  • Endothelial protein C receptor and scavenger receptor class B type 1 are major autoantigens in Takayasu arteritis
    (JCR International School 2019 2019)
  • Endothelial protein C receptor and scavenger receptor class B type 1 are major autoantigens in Takayasu arteritis
    (JCR 2019 Annual Scientific Meeting 2019)
  • Identification of endothelial protein C receptor and scavenger receptor class B type 1 as major autoantigens in Takayasu arteritis
    (EULAR 2019 2019)
  • Insufficient Use of Corticosteroids Results in Higher Relapse in Takayasu Arteritis
    (American College of Rheumatology Annual Meeting 2018 2018)
ｍore...
Education (2)：
  • 2015 - 2019 Tohoku University Faculty of Medicine
  • 2006 - 2012 Tohoku University Faculty of Medicine School of Medicine
Professional career (1)：
  • 医学博士 (東北大学)
Work history (1)：
  • 2019/04 - 現在 東北大学病院 血液・免疫科 医員
Awards (1)：
  • 2019/04 - JCR2019国際ワークショップ優秀演題賞
Association Membership(s) (2)：
JAPAN COLLEGE OF RHEUMATOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM